The manufacturer and provider of over 21,000 validated primary antibodies targeting all human proteins.
Location: Sweden, Stockholm
Employees: 51-200
Founded date: 2006
Investors 1
| Date | Name | Website |
| 07.03.2021 | Ideon Scie... | ideon.se |
Mentions in press and media 4
| Date | Title | Description |
| 23.06.2026 | Changes to Mölnlycke Health Care Board of Directors | Changes to Mölnlycke Health Care Board of Directors Tue, Jun 23, 2026 12:00 CET Report this content Gothenburg, Sweden. 23 June 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces changes to its Board of Di... |
| 23.04.2026 | AAX Biotech and evitria to expand access to Opti-mAb® technology in early antibody development | AAX Biotech and evitria to expand access to Opti-mAb® technology in early antibody development Thu, Apr 23, 2026 08:50 CET Report this content Biotech company AAX Biotech, a leading innovator in technologies for antibody-based therapies, to... |
| 04.06.2025 | Filippa Stenberg joins Mölnlycke Board of Directors | Filippa Stenberg joins Mölnlycke Board of Directors Wed, Jun 04, 2025 08:00 CET Report this content Gothenburg, Sweden. 4 June 2025. Mölnlycke is pleased to announce the election of Filippa Stenberg as a deputy board member to its Board of ... |
| 03.08.2021 | Atlas Antibodies acquires biotech service provider evitria | Since its inception in 2010, evitria is a biotech service provider focused on the transient expression of recombinant antibodies in CHO cells. This long-standing and deep focus allows the company to deliver antibodies of exceptional quality... |